J.-P. Devogelaer

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 1.1K citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

Ian R. Reid, Jacques P. Brown, P. Burckhardt et al. · New England Journal of Medicine · 2002 · 876 citations · Full text

Medicine, Pharmacotherapy, Bioavailability +12

Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium Alone

Y. Boutsen, Jacques Jamart, W. Esselinckx et al. · Journal of Bone and Mineral Research · 2001 · 162 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Risedronate Increases Bone Density and Reduces Vertebral Fracture Risk Within One Year in Men on Corticosteroid Therapy

Donald Reid, S. Adámi, J.-P. Devogelaer et al. · Calcified Tissue International · 2001 · 161 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years

Jean‐Yves Reginster, Olivier Bruyère, Adam Sawicki et al. · Bone · 2009 · 121 citations

Medicine, Endocrinology, Bone Metabolism +13